Lee et al.
|
2017
|
68 (68)
|
48(16–73)
|
8.5(5.2–10)
|
Monobloc Cementless[Corail, DePuy]
|
NA
|
2.2(−2–14)
|
NA
|
HHS: 91 (73–100) UCLA activity: 5.5 (3–8)
|
None
|
Sciatic nerve palsy: 1 Ectopic ossification: 9
|
100%
|
Huang et al.
|
2016
|
33(33)
|
46.8 (24–72)
|
4.5 (2.2–11.3)
|
Various: Monobloc cementless: 22 Modular Femoral Component[SROM, DePuy]: 11
|
NA
|
NA
|
HHS: 37.6 (15–56)
|
HHS: 92.8(70–100) Diminished or no limping: 45% (15/33) dissatisfied: 9.1%(3/33)
|
None
|
Ectopic ossification: 2 Sciatic nerve palsy: 1 Intraoperative fracture: 4
|
NA
|
Lee et al.
|
2016
|
37(41)
|
43.8 ± 12.7 (18.9–66.3)
|
10.4 ± 3.3 (5.2–16.0)
|
Aluminae-alumina Cementless
|
20 ± 12
|
2 ± 9
|
HHS:66.7 ± 17.4
|
HHS: 96.8 ± 6.8 Lengthening: 17 ± 9 Diminished or no limping: 97% (36/37)
|
None
|
Intraoperative fracture: 14 Peroneal nerve palsy: 1 Deep vein thrombosis: 1
|
NA
|
Seufert et al.
|
2015
|
28(35)
|
51.6 (22–74)
|
8.2 (2–14)
|
Modular Femoral Component[SROM, DePuy]
|
18.6
|
7
|
HHS: 49.8 ± 9.2
|
HHS: 93.9 ± 8.5 Diminished or no limping: 94.3% (33/35)
|
Deep Infection: 1
|
Ectopic ossification: 2 Dislocation: 1
|
NA
|
Lim et al.
|
2014
|
23(23)
|
49.2 (25–69)
|
3.5 (2–7)
|
Monobloc Cementless: Bencox II 22,Accolade 1
|
15 (7–25)
|
3 (1–7)
|
HHS: 48.3 (42–67)
|
HHS: 92.4 (79–97)
|
Sciatic nerve palsy: 1
|
Sciatic nerve palsy: 1 Intraoperative fracture: 3
|
96%
|
Al-Khateeb et al.
|
2014
|
14(15)
|
32.8 (23–55)
|
10.1 (5–15)
|
Custom-made Cementless
|
NA
|
NA
|
HHS: 41(27–57) Trendelenburg sign(+): 11(78%) Walking aids: 8
|
HHS: 80(51–94) Trendelenburg sign(+): 3(21%) Walking aids: 1
|
Aseptic loosening: 3 Deep infection: 1
|
Ectopic ossification: 1 Dislocation: 1
|
Femoral stem: 100% Acetabular components: 79%
|
Baghdadi et al.
|
2013
|
95(99)
|
48 ± 15
|
8 ± 5
|
Cementless implants: 76 Hybrid implants:21
|
NA
|
NA
|
HHS: 56 (25–85)
|
HHS: 88 (50–100)
|
Aseptic loose stem component: 5 Liner wear: 3 Aseptic loose cup component: 1 Deep infection: 1
|
Intraoperative fracture: 8 (femoral), 1 (acetabular) Sciatic nerve palsy: 3 Thromboembolic: 1 Infection: 1 Dislocation: 1 Adductor tenotomy: 1
|
Cementless implants:90% (76%–96%) Hybrid implants:86% (57%–96%)
|
Traina et al.
|
2011
|
27(32)
|
37.8(19–65)
|
12.3(5–21)
|
Cement-less: 31 Cemented:1
|
NA
|
9(0–26)
|
HHS: 50.1(25–75)
|
HHS: 87.5 (73–96) Average Lengthening: 12 (6–27)
|
Failure for cemented component: 1
|
Sciatic nerve palsy: 2 Intraoperative fracture: 1 Hematoma: 1
|
96.9%(90.8% -100.0%)
|
Pietrzak et al.
|
2011
|
9(9)
|
56(41–69)
|
15(11–21)
|
Cement-less: 6 Cemented:3
|
NA
|
NA
|
HHS: 34 WOMAC: 77
|
HHS: 93 WOMAC: 6
|
None
|
NA
|
100%
|
Current study
|
2017
|
71(88)
|
49.94 ± 11.40(36–73)
|
10.09 ± 1.84(7.7–14)
|
Monobloc cementless: 88
|
24.3 ± 7.8(8–36)
|
2.4 ± 2.8(−2–10)
|
HHS: 46.42 ± 6.11, Sym: 11.37 ± 2.40, Pain:19.39 ± 5.90, DL: 34.80 ± 3.78, SARA: 8.07 ± 1.77, QOF: 6.62 ± 1.21, PCS: 15.80 ± 2.69, MCS: 16.63 ± 2.80
|
HHS: 89.70 ± 5.46, Sym: 17.19 ± 1.45, Pain:37.32 ± 2.05, DL: 65.77 ± 1.17, SARA: 14.55 ± 1.96, QOF: 13.42 ± 1.31, PCS: 23.11 ± 2.78, MCS: 24.55 ± 3.13
|
Fracture: 1
|
Intraoperativel fracture: 2 Sciatic nerve palsy:2 Heterotopic ossification: 2 Dislocation: 1 Thigh pain: 1
|
98.3%(94.9%–99.9%)
|